Accuray Inc

ARAY

Company Profile

  • Business description

    Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

  • Contact

    1240 Deming Way
    MadisonWI53717
    USA

    T: +1 608 824-2800

    E: [email protected]

    https://www.accuray.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2027

    Employees

    809

Stocks News & Analysis

stocks

Anthropic and OpenAI face commodification threats. Here’s what to watch for

Frontier AI labs face a three-pronged set of challenges.
stocks

Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment

We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
stocks

Overlooked cheap ASX share

The market may be overlooking this share’s long-term value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,975.7035.300.39%
CAC 407,868.0588.65-1.11%
DAX 4025,319.77302.84-1.18%
Dow JONES (US)51,966.0336.38-0.07%
FTSE 10010,764.69117.21-1.08%
HKSE24,186.83124.110.52%
NASDAQ26,430.89290.851.11%
Nikkei 22564,916.70407.59-0.62%
NZX 50 Index13,652.07101.66-0.74%
S&P 5007,690.7331.290.41%
S&P/ASX 2008,845.7039.000.44%
SSE Composite Index3,716.288.810.24%

Market Movers